Biktarvy 50-200-25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F7VA9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,953
Award facts
- Contract value 100% obligated
- $32,953.23 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $32,953.23 delivery order to AmerisourceBergen Drug Corp for 30-unit supplies of Biktarvy 50-200-25 mg tablets, with an ultimate completion date of January 13, 2026. This competitive, non-set-aside contract uses firm fixed-price pricing and represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through its comprehensive portfolio of brand-name and generic medications.
This delivery order falls under AmerisourceBergen's prime Indefinite Delivery Contract with DLA valued at $999,999,999.00 through December 2026, which functions as a global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to military healthcare programs worldwide. The parent company, Cencora, Inc. (doing business as AmerisourceBergen), holds the underlying $999,999,999.00 IDC with DLA through December 31, 2031. The Biktarvy tablets supplied under this order are antiretroviral medications used for HIV treatment, reflecting the breadth of specialty pharmaceuticals that AmerisourceBergen distributes to support federal healthcare operations across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F7VA9?
SPE2DR26F7VA9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26F7VA9 worth?
The government has obligated $32,953 on SPE2DR26F7VA9.
Is contract SPE2DR26F7VA9 an order under another contract?
Yes. SPE2DR26F7VA9 is a delivery order under SPE2DR25D2216, an indefinite delivery contract.
Was contract SPE2DR26F7VA9 competed?
The extent of competition for SPE2DR26F7VA9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award